Key highlights
- Global prices for excipients and selected APIs will increase up to 20%.
- The price adjustment takes effect immediately or as allowed by existing contracts.
- Cited reason: rising global energy and raw-material costs; the company will monitor the market and may announce further adjustments.
Announcement
Florham Park, New Jersey, March 30, 2026 — BASF Pharma Solutions announced a global price increase of up to 20% for excipients and selected active pharmaceutical ingredients (APIs) it supplies.
Effective date and scope
The adjustment takes effect immediately or as permitted under existing contracts and applies across the company's excipient and selected API portfolio.
Reasoning and follow-up
BASF cites rising global energy and raw-material costs as the rationale and says it will continue to monitor market conditions and communicate any further adjustments as needed.
Definitions
Excipients are inactive ingredients that support pharmaceutical formulations; APIs are the active components responsible for medicines' therapeutic effects.
